Leaflet PRIMALAN 5mg tablets


Indicated for: allergic rhinitis; urticaria

Substance: mequitazine (antiallergic agent)

ATC: R06AD07 (Respiratory system | Antihistamines for systemic use | Phenothiazine derivatives)

Mequitazine is an H1 antihistamine used for the treatment of allergic symptoms such as allergic rhinitis and urticaria. It works by blocking H1 histamine receptors, thereby reducing allergic symptoms like itching, sneezing, and nasal discharge.

The medication is taken orally, as directed by a doctor, usually once or twice daily. It is important for patients to follow the recommended dosage to avoid adverse effects.

Patients should be aware of potential side effects, such as drowsiness, dry mouth, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dry mouth, and dizziness. In rare cases, severe reactions such as allergic reactions or cardiac disorders may occur. Patients should be informed of these risks before use.

General data about PRIMALAN 5mg

  • Substance: mequitazine
  • Date of last drug list: 01-07-2013
  • Commercial code: W07331002
  • Concentration: 5mg
  • Pharmaceutical form: tablets
  • Quantity: 14
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for mequitazine

Concentrations available for mequitazine

  • 0.05%
  • 10mg
  • 5mg